.svg)
Commercialization doesn’t usually fail all at once.
It breaks quietly as decisions drift.
Most launch issues aren’t caused by bad strategy or weak execution.
They emerge when early decisions are interpreted differently as work moves across functions, partners, and timelines. Over time, that drift compounds.
Evidence is shaped without full consideration of downstream access or activation implications.
Value stories evolve as they move between medical, access, and commercial teams.
Activation accelerates — but alignment erodes.
Drift is never intentional. All drift is predictable.
Drift and fracture never shows up in planning decks or launch checklists.
It appears later as:
Rework
MLR delays
Inconsistent messaging
Access friction
Lost confidence
By then, fixing it means slowing down, rewriting, or starting over.
Commercialization risk isn’t a capability gap.
It’s a decision adherence problem.
